Filing Details
- Accession Number:
- 0001127602-20-025577
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-22 17:11:04
- Reporting Period:
- 2020-09-21
- Accepted Time:
- 2020-09-22 17:11:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1690927 | Zvi Tal Zaks | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-09-21 | 10,000 | $20.93 | 10,000 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-09-21 | 10,000 | $19.15 | 20,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-09-21 | 3,400 | $66.16 | 16,600 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-21 | 10,601 | $67.11 | 5,999 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-21 | 4,210 | $67.94 | 1,789 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-21 | 1,789 | $69.06 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-09-21 | 10,000 | $0.00 | 10,000 | $20.93 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-09-21 | 10,000 | $0.00 | 10,000 | $19.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
219,195 | 2020-03-08 | 2029-03-08 | No | 4 | M | Direct |
124,790 | 2026-08-10 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.62 to $66.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.64 to $67.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.68 to $68.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.79 to $69.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- This option is fully vested and exercisable.